Tekla Capital Management Investments & Fund Profile

Overview

Investment adviser for healthcare and life sciences equity funds.

Founded

1986

Deals · 12mo

0

Links

Website LinkedIn

Stage focus

Series B

Series C

Geographic focus

Switzerland

United States

Sector focus

Finance

Financial Services

Health Care

Venture Capital

Investment portfolio

42rounds

LedParticipated

NAME	DATE	SIZE
Abcuro	Aug 2023Participated	$155 MSeries B
Amolyt Pharma	Jan 2023Participated	$137 MSeries C
Invetx	May 2022Participated	$61 MSeries B
Endeavor BioMedicines	Feb 2022Participated	$101 MSeries B
Quell Therapeutics	Nov 2021Participated	$156 MSeries B
HotSpot Therapeutics	Nov 2021Participated	$100 MSeries C
Arbor Biotechnologies	Nov 2021Participated	$215 MSeries B
Parthenon Therapeutics	Nov 2021Participated	$65 MSeries A
ReCode Therapeutics	Oct 2021Participated	$80 MSeries B
Aristea Therapeutics	Jul 2021Participated	$63 MSeries B
ImmuneID	Jun 2021Participated	$50 MSeries A
HiberCell	May 2021Participated	$97 MSeries B
Abcuro	Aug 2023Participated	$155 MSeries B
Amolyt Pharma	Jan 2023Participated	$137 MSeries C
Invetx	May 2022Participated	$61 MSeries B
Endeavor BioMedicines	Feb 2022Participated	$101 MSeries B
Quell Therapeutics	Nov 2021Participated	$156 MSeries B
HotSpot Therapeutics	Nov 2021Participated	$100 MSeries C
Arbor Biotechnologies	Nov 2021Participated	$215 MSeries B
Parthenon Therapeutics	Nov 2021Participated	$65 MSeries A
ReCode Therapeutics	Oct 2021Participated	$80 MSeries B
Aristea Therapeutics	Jul 2021Participated	$63 MSeries B
ImmuneID	Jun 2021Participated	$50 MSeries A
HiberCell	May 2021Participated	$97 MSeries B

42 Items

42

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Tekla Capital Management: 42 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	0	6
Series B	1	14
Series C+	1	14
Other Equity	0	5
Debt	0	1

Monthly Deal Activity

Tekla Capital Management: 42 deals are recorded across 177 months. All available history
Month	Deals
Feb '12	1
Mar '12	0
Apr '12	0
May '12	0
Jun '12	0
Jul '12	0
Aug '12	0
Sep '12	1
Oct '12	0
Nov '12	0
Dec '12	0
Jan '13	0
Feb '13	0
Mar '13	0
Apr '13	0
May '13	0
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	0
Jan '14	0
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	0
Dec '14	1
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	1
Jul '15	1
Aug '15	2
Sep '15	0
Oct '15	0
Nov '15	0
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	1
Apr '17	0
May '17	0
Jun '17	0
Jul '17	0
Aug '17	1
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	0
Mar '18	0
Apr '18	0
May '18	1
Jun '18	0
Jul '18	1
Aug '18	1
Sep '18	2
Oct '18	2
Nov '18	0
Dec '18	0
Jan '19	1
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	1
Oct '19	0
Nov '19	1
Dec '19	0
Jan '20	1
Feb '20	0
Mar '20	0
Apr '20	1
May '20	2
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	1
Oct '20	2
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	2
Apr '21	0
May '21	3
Jun '21	1
Jul '21	1
Aug '21	0
Sep '21	0
Oct '21	1
Nov '21	4
Dec '21	0
Jan '22	0
Feb '22	1
Mar '22	0
Apr '22	0
May '22	1
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	1
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	1
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Tekla Capital Management: Health & Life Sciences is the largest displayed sector by deal count (42 deals). All available history
Sector	Deals
Health & Life Sciences	42
Developer Tools	2
Education & Workforce	1
Manufacturing	1
Social & Community Platforms	1
Consumer & Lifestyle	1

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Tekla Capital Management: 42 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	0
$5M-$10M	0
$10M-$25M	2
$25M-$50M	6
$50M-$100M	23
$100M-$250M	11
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 3 of 3 regions; European countries are grouped as Europe.

Tekla Capital Management: United States has the largest recorded deal count among the displayed regions (30 deals). All available history
Region	Deals
United States	30
Europe	10
Canada	2

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Tekla Capital Management: 20 co-investors are shown, with Novo Holdings sharing 9 recorded deals. All available history
Co-investor	Shared deals
Novo Holdings	9
Pfizer Ventures	7
EQT Life Sciences (LSP)	6
Bpifrance	5
Fidelity Management & Research Company	5
Janus Henderson Investors	5
OrbiMed	5
Redmile Group	5
Surveyor Capital	5
Cormorant Asset Management	4
Monashee Investment Management	4
New Leaf Venture Partners	4
Perceptive Advisors	4
Pontifax	4
RA Capital Management	4
Ridgeback Capital Investments	4
Sofinnova Ventures	4
Alexandria Venture Investments	3
Alta Partners	3
ARCH Venture Partners	3